Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-18-000405
Filing Date
2018-10-10
Accepted
2018-10-10 10:23:12
Documents
1
Effectiveness Date
2018-10-10

Document Format Files

Seq Description Document Type Size
1 8A_Cert_ALLO.pdf CERT 111067
  Complete submission text file 0001354457-18-000405.txt   154119
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-38693 | Film No.: 181115154
SIC: 2836 Biological Products, (No Diagnostic Substances)